INVESTOR PRESENTATION NASDAQ: PDSB | January 2023 PDS Biotechnology Precision Designed Science For Immunotherapy Forward-Looking Statements Certain information in this presentation may include forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the "Company") and other matters. These statements may discuss goa ...